Company News

Recently, the group standard *"Efficacy Evaluation of Probiotics in Obesity and Metabolic Syndrome" (T/FDSA 0155—2026)* was officially implemented. Developed under the leadership of a national-level industry authority, this standard standardizes the efficacy validation, evaluation dimensions, and judgment criteria for related products. It establishes, for the first time in China, a foundational system for evaluating the metabolic health efficacy of probiotics, filling an industry gap and laying the cornerstone for the standardized and scientific development of this specialized field.

When "comprehensive health" evolves from a fleeting trend into the defining ethos of our era, and "scientific nutrition" becomes the core demand of consumers, the boundaries between the food and health industries are being redrawn. We now stand at a brand-new starting point—a "great era of nutrition" driven by scientific evidence and centered on precision nutrition. 

Bioyitech, as one of the first enterprises, has been invited to participate in the pilot and development of the State Administration for Market Regulation's "Internet + AI Regulation" Platform Interface and Data Collection Specifications. This recognition affirms its "Smart Factory" achievements at the national level and officially positions the company among the industry standard-setters, establishing a new benchmark of "AI + Food Safety" for the probiotics industry.

Food Ingredients China is the world’s largest and most international professional exhibition for the food additives and ingredients industry.It brings together all top international giants such as Cargill, IFF, and DSM-Firmenich, making it the preferred platform for companies to launch new products.Through the Food Industry Academician Forum and the China-International Regulations and Standards Forum,” it establishes a high-end and professional exchange system.

The 28th China International Food Additives and Ingredients Exhibition (FIC 2026) successfully concluded from March 17 to 19, 2026, at the National Exhibition and Convention Center (Hongqiao) in Shanghai.

From December 18-19, 2025, the "2025 Sports and Nutrition Food Technology and Application Innovation Conference," hosted by authoritative Chinese food industry platforms FFI & "Food Wanli Xing," was grandly held in Shanghai. 

On December 3rd, Fengxian District successfully hosted the 2025 Xian Shang Conference, bringing together nearly 450 entrepreneurs and chamber of commerce representatives from various industries within the district to discuss new avenues for the development of the private economy.

From November 13th to 15th, the 7th International Conference on Functional Medicine convened in Beijing. This significant event brought together leading global experts, clinicians, and industry representatives in the field of functional medicine to discuss the latest progress in disease prevention, health management, and industrial development.

The two-day 2025 Novel Nutrition Conference recently concluded successfully in Guangzhou. At this conference, Bioyitech made a significant debut with its exclusive product, Bioyitech's strains (Booth No.: A09).

The 2025 Western United States International Health Industry Expo (hereinafter referred to as the "Western U.S. Expo"), the world's most influential health technology event, recently concluded successfully in Las Vegas.